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ABSTRACT
UHRF2 is a ubiquitin-protein ligase E3 that regulates cell
cycle, genomic stability and epigenetics. We conducted
a co-immunoprecipitation assay and found that TIP60
and HDAC1 interact with UHRF2. We previously
demonstrated that UHRF2 regulated H3K9ac and
H3K14ac differentially in normal and cancer cells.
However, the accurate signal transduction mechanisms
were not clear. In this study, we found that TIP60 acted
downstream of UHRF2 to regulate H3K9ac and H3K14ac
expression. TIP60 is stabilized in normal cells by UHRF2
ubiquitination. However, TIP60 is destabilized in cancer
cells. Depletion or inhibition of TIP60 disrupts the reg-
ulatory relationship between UHRF2, H3K9ac and
H3K14ac. In summary, the ﬁndings suggest that UHRF2
mediated the post-translational modiﬁcation of histones
and the initiation and progression of cancer.
KEYWORDS UHRF2, TIP60, ubiquitination, acetylation,
hepatocellular carcinoma
INTRODUCTION
Post-translational modiﬁcations (PTMs) of histones regulate
gene expression. They are induced by several families of
proteins including histone deacetylases (HDACs), histone
acetyltransferases (HATs), physphorylases of the aurora
kinases family, and histone ubiquitinases of the E3 ligase
family (Basu et al., 2009; Pokholok et al., 2005; Tan et al.,
2011; Wang et al., 2008). These modiﬁcations involving the
interaction between histone and DNA regulate gene tran-
scription either synergistically or antagonistically (Arnaudo
and Garcia 2013; Su et al., 2016). UHRF2 is a multi-domain
E3 ubiquitin ligase, which is related to mouse Np95 and
human ICBP90. It comprises UBL, PHD, TTD, SET and
RING-associated (SRA/YDG) and RING ﬁnger domains
(Bronner et al., 2007; Qian et al., 2012; Wang et al., 2012).
Several studies have demonstrated that UHRF2 represents
a nodal point in the cell cycle network and regulates the
epigenetics (Mori et al., 2011). UHRF2 interacts with the
DNA methyltransferases (DNMT1, DNMT3a and DNMT3b),
HDAC1, G9a and H3K9me2/me3 (Li et al., 2004; Mori et al.,
2004; Pichler et al., 2011). Recently we found that UHRF2
inﬂuenced the acetylation of histone H3 on lysine 9
(H3K9ac) and lysine 14 (H3K14ac). However, the molecular
mechanism was unclear. We investigated the mechanism
underlying UHRF2-mediated regulation of H3K9ac and
H3K14ac expression and the factors associated with differ-
ential regulation in normal and cancer cells.
Histone acetyltransferase TIP60 attracted our interest. It
belongs to the MYST family and controls the acetylation of
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histone H2A on lysine 5 (H2AK5), histone H3 on lysine 14
(H3K14) and histone H4 (lysines 5, 8, 12, and 16) (Dai
et al., 2013; Ikura et al., 2015; Jacquet et al., 2016; Renaud
et al., 2016). TIP60 also participates in DNA repair, cellular
growth, apoptosis and response to DNA double-strand
breakage (Grezy et al., 2016; Jang et al., 2015; Sun et al.,
2015). Recently, it was demonstrated that UHRF1 recruits
histone acetyltransferase TIP60 and controls its expression
and activity (Achour et al., 2009). In this study, the inter-
actions between TIP60 and UHRF2 were detected using
co-immunoprecipitation. It is suggested that TIP60 regu-
lates H3K9ac and H3K14ac as downstream signal
molecules.
We identiﬁed a previously undeﬁned mechanism associ-
ated with TIP60-mediated UHRF2-regulation of H3K9ac and
H3K14ac expression. In normal cells, UHRF2 overexpres-
sion enhances the expression of H3K9ac and H3K14ac,
which is reversed in cancer cells. The regulatory mechanism
is disrupted following deletion of the YDG or RING ﬁnger
domains of UHRF2. In HEK293 cells, the interaction
between UHRF2, TIP60 and HDAC1 was detected with co-
immunoprecipitation, which was mediated via PHD and
RING ﬁnger domains of UHRF2. Further, we found that
TIP60 was a key intermediate in this molecular mechanism.
Inhibition of TIP60 expression or activity disrupted the reg-
ulatory relationship. We also determined the levels of
UHRF2, H3K9ac, H3K14ac, TIP60 and H2AK5ac in human
hepatocellular carcinoma (HCC) tissues immunohistochem-
ically. The results showed that all the aforementioned pro-
teins were decreased under the high expression of UHRF2
in HCC tissues.
In summary, we identiﬁed a new mechanism underlying
UHRF2-TIP60-H3K9ac and H3K14ac signaling axis. UHRF2
may contribute to the initiation and development of primary
hepatocellular cancer by TIP60, which warrants further
investigation.
RESULTS
UHRF2 regulates the expression of H3K9ac
and H3K14ac
To determine the relationship between UHRF2, H3K9ac and
H3K14ac, Western blot was performed. In normal cells
(HEK293 and LO2 cells), UHRF2 overexpression elevated
the expression of H3K9ac and H3K14ac compared with that
of the control group. Opposite ﬁndings were observed in
cancer cells (HepG2 cells) (Fig. 1A and 1B). Depletion of
UHRF2 in HEK293 and LO2 cells lowered the expression of
H3K9ac and H3K14ac compared with those of the control
group. Similarly, HepG2 cells showed an inverse relationship
(Fig. 1C and 1D) suggesting totally opposite results of the
regulatory mechanism of UHRF2, H3K9ac and H3K14ac in
different cells. Furthermore, we found that the YDG and
RING ﬁnger domains of UHRF2 were required for this reg-
ulatory mechanism, based on Western blot and immunoﬂu-
orescent assays (Fig. 1F–J). UHRF2 is an E3 ligase
belonging to the RING-ﬁnger family, and the RING ﬁnger
domain is required for E3 ligase activity. These results sug-
gested that UHRF2 ligase activity was required for the reg-
ulatory mechanism.
UHRF2 interacts with TIP60 and HDAC1
Recent studies conﬁrmed that UHRF1 recruits TIP60 and
controls its expression and activity (Achour et al., 2009).
UHRF2 was implicated in epigenetics via association with
DNMTs, G9a, HDAC1, H3K9me2/3 and hemi-methylated
DNA (Mori et al., 2011; Pichler et al., 2011). Both UHRF2 and
UHRF1 belong to the UHRF family and show 67% sequence
similarity (Bronner et al., 2007). Hence, we hypothesized
that UHRF2 regulates H3K9ac and H3K14ac expression
probably via TIP60 or HDAC1. A co-immunoprecipitation
assay was performed to establish the interaction between
UHRF2, TIP60 and HDAC1. A signiﬁcant TIP60 and HDAC1
immunoprecipitation was observed using Flag-UHRF2
(Fig. 2A). In Fig. 2B and 2C, the reciprocal co-immunopre-
cipitation was performed and the interaction between
UHRF2, TIP60 and HDAC1 was veriﬁed. In Fig. 2D, we
demonstrated that the PHD and RING ﬁnger domains of
UHRF2 were key domains in the interaction. Deletion of the
PHD or RING ﬁnger domain of UHRF2 disrupted the inter-
action between UHRF2 and TIP60. However, the interaction
between UHRF2 and HDAC1 was not affected. The trans-
formation was not caused by the mis-localization of the
deletion mutants of UHRF2. Double immunoﬂuorescent
staining revealed co-localization of UHRF2, TIP60 and
HDAC1 proteins in LO2 cells (Fig. 2E and 2F) suggesting
that UHRF2 interacted with TIP60 and HDAC1, and the
interaction between UHRF2 and TIP60 was induced via the
PHD and RING ﬁnger domains of UHRF2.
Figure 1. UHRF2 regulates the expression of H3K9ac and
H3K14ac. (A) HEK293, LO2 and HepG2 cells were transfected
with the indicated plasmids. Cellular lysates were analyzed by
Western blot. UHRF2 was detected using anti-Flag antibodies.
H3 and GAPDH were used as loading controls. (B) H3K9ac and
H3K14ac levels were normalized to 1 at control groups.
Signiﬁcance was represented as *P < 0.05. (C and D)
Endogenous UHRF2 protein levels were decreased by shRNA
against UHRF2. The cellular lysates were analyzed by Western
blot and quantiﬁed using Image J software. (E) Various UHRF2
deletion mutants; (F–H) HEK293, LO2 and HepG2 cells were
transiently transfected with indicated plasmids. After 48 h, the
cellular lysates were analyzed by Western blot. (I and J)
Immunoﬂuorescence analyses were performed using anti-
H3K9ac or anti-H3K14ac antibodies.
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UHRF2 enhances the expression and activity of TIP60
To address the physiological relevance of these interactions,
we tested whether modulation of the cellular levels of
UHRF2 affected the TIP60 levels and activity. Recent stud-
ies emphasized the role of TIP60 as a unique histone
acetyltransferase for the acetylation of H2AK5, which is
considered as an endogenous marker of TIP60 activity
(Bhaumik et al., 2007). In Fig. 3A, 3C and 3E, UHRF2
overexpression in normal cells induced a signiﬁcant increase
of TIP60 levels and activity, which was reversed in cancer
cells. However, no obvious alteration in HDAC1 protein
levels was observed. These results suggested that the
expression and activity of TIP60 were increased by UHRF2
in normal cells, but decreased in cancer cells. In addition, we
employed shRNA to suppress endogenous UHRF2. The
results showed that ablation of endogenous UHRF2
decreased TIP60 activity in normal cells, but increased in
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Figure 2. UHRF2 interacts with TIP60 and HDAC1. (A) HEK293 cells were transfected with control or Flag-UHRF2 plasmids,
respectively. After 48 h, the total cellular lysates were immunoprecipitated using anti-Flag antibodies. (B) HEK293 cells were
transfected with plasmids as shown. Cellular lysates were immunoprecipitated with anti-TIP60 antibodies and analyzed by Western
blot. (C) HEK293 cells were transfected with the indicated plasmids. Total cellular lysates were subjected to HDAC1
immunoprecipitation. (D) HEK293 cells were transfected with full-length UHRF2 or various deletion mutant constructs of UHRF2
plasmids. Cellular lysates were immunoprecipitated using anti-Flag antibodies and analyzed by Western blot. (E and F) Double-
labeling immunoﬂuorescence combined with CLSM observation revealed co-localization of TIP60 and UHRF2 in LO2 cells. Co-
localization of HDAC1 and UHRF2 was also revealed along with nuclear expression of all proteins.
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signiﬁcant variation (Fig. 3B, 3D and 3F). Additional inves-
tigations showed that deletion of the PHD or RING ﬁnger
domains of UHRF2 abolished the regulatory relationship
(Fig. 3G-I), which suggested that PHD and RING ﬁnger
domains of UHRF2 were the key domains in this mecha-
nism. Furthermore, immunoﬂuorescence staining showed
similar results indicating that the PHD and RING ﬁnger
domains of UHRF2 were pivotal domains (Fig. 3J and 3K)
and that the ligase activity of UHRF2 was required.
UHRF2 ubiquitinates and stabilizes TIP60
To explore whether UHRF2 stabilizes TIP60, a half-life
experiment was performed. Under controlled conditions,
TIP60 showed a half-life of less than 1 h, which was
extended by UHRF2 in normal cells. Deletion of RING ﬁnger
domain in UHRF2 abrogated the effect. In cancer cells, the
degradation of TIP60 was accelerated by UHRF2 (Fig. 4A–
C). These results showed that UHRF2 regulated TIP60
stability via RING ﬁnger domain differentially in normal and
cancer cells. UHRF2 is an E3 ligase and mediates ubiquiti-
nation. In this condition, we hypothesized that UHRF2 might
ubiquitinate TIP60 in vivo. The results showed that TIP60
was immunoprecipitated with anti-HA-Ub antibodies, and
was clearly enhanced in the UHRF2-overexpressing group
of HEK293 cells (Fig. 4D). Similar results were not observed
in HepG2 cells (Fig. 4E) indicating that UHRF2 stabilized
TIP60 expression via RING ﬁnger domain through
ubiquitination.
UHRF2 regulates H3K9ac and H3K14ac expression
via interaction with TIP60
Previous studies indicated that TIP60 regulated H3K9ac and
H3K14ac expression (Ikura et al., 2015; Renaud et al., 2016;
Bassi et al., 2016). In this study, we found similar results in
normal and cancer cells (Figure S1). We also suggested that
UHRF2 regulated H3K9ac and H3K14ac expression. Hence,
we hypothesized that UHRF2 regulates H3K9ac and
H3K14ac through TIP60. In Fig. 5A–C, ablation of endoge-
nous TIP60 decreased H3K9ac and H3K14ac protein levels,
whereas overexpression of UHRF2 failed to rescue the
altered normal cells. In cancer cells, ablation of TIP60 and
UHRF2 overexpression further decreased H3K9ac and
H3K14ac protein levels. Moreover, co-expression of UHRF2
and TIP60 increased the protein levels of H3K9ac and
H3K14ac in normal cells. However, the protein levels of
H3K9ac and H3K14ac were not rescued by the co-expres-
sion of TIP60 and UHRF2 in cancer cells (Fig. 5D–F). These
results clearly showed that TIP60 as a downstream molecule
of UHRF2 enhanced the expression of H3K9ac and
H3K14ac. We also inhibited TIP60 acetyltransferase activity
using a speciﬁc inhibitor MG149 that targets acetyl CoA-
binding sites. The results showed that inhibition of TIP60
acetyltransferase activity during transfection of full-length
UHRF2 or the deletion mutant construct of UHRF2 failed to
rescue H3K9ac and H3K14ac expression (Fig. 5G–I). Thus,
we concluded that UHRF2 regulated H3K9ac and H3K14ac
expression via TIP60 downstream.
Inverse correlation between TIP60 and UHRF2 in HCC
tissues
In this study, we found that UHRF2 regulated H3K9ac and
H3K14ac expression via interaction with TIP60 in cultured
cells. We investigated the regulatory mechanism in human
hepatocellular carcinoma tissues using immunohistochem-
istry. A signiﬁcant decrease in the expression of TIP60,
H3K9ac, H3K14ac and H2AK5ac was found following the
elevated expression of UHRF2 in HCC tissues (Fig. 6A).
However, in the adjacent non-tumor tissues, a positive cor-
relation between the aforementioned proteins and UHRF2
was observed (Fig. 6B). Similar results were clearly found in
human tissues compared with in vitro results. Accordingly,
we established that UHRF2 regulated the expression of
H3K9ac and H3K14ac by stabilizing TIP60 via proteasomal
pathway through its RING domain. We developed a model of
UHRF2-TIP60-H3K9ac and H3K14ac signaling axis
(Fig. 6C).
DISCUSSION
TIP60 is a transcriptional co-factor involved in several
essential physiological processes in cells. Its aberrant
expression has been reported in several cancers (Feng
et al., 2016; Mo et al., 2016). TIP60 plays a major role in
histone acetylation to potentially trigger cancer-related gene
expression (Sun et al., 2015). A previous study showed that
TIP60 co-localizes with the UHRF1/DNMT1 complex, which
is involved in ubiquitination as a substrate of E3 ligase (Dai
et al., 2013). Our ﬁndings strongly suggested that TIP60 was
a new substrate for UHRF2. Protein modiﬁcation via ubiq-
uitination is of great importance in many regulatory pro-
cesses inside the cells (Hershko et al., 2000). Ubiquitination
alters protein turnover via proteasome-mediated degradation
of proteins (Harrison et al., 2016; Leithe 2016; Yamano et al.,
Figure 3. UHRF2 regulates the expression and activity of
TIP60. (A, C and E) HEK293, LO2 and HepG2 cells were
transfected with control or Flag-UHRF2 plasmids. They were
exposed to MG132 (10 μg/mL) for 12 h and harvested. The
cellular lysates were analyzed by Western blot. (B, D and F)
HEK293, LO2 and HepG2 cells were transfected with shNC or
shUHRF2. After 48 h, the total cellular lysates were analyzed by
Western blot. Data were expressed as means ± SD, n = 3.
Signiﬁcance was indicated as *P < 0.05, and non-signiﬁcance
as n.s P > 0.05. (G–I) HEK293, LO2 and HepG2 cells were
transfected with the plasmids as shown. The cellular lysates
were analyzed by Western blot. (J and K) Immunoﬂuorescence
analyses were performed using anti-TIP60 or anti-HDAC1
antibodies.
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2015; Lechtenberg et al., 2016). Altered ubiquitination may
prolong the half-life of speciﬁc proteins, while other proteins
are rapidly degraded (Vinther-Jensen et al., 2015). In ubiq-
uitination pathway, the E3 ligase plays an important role in
substrate recognition. In this study, we found that E3 ligase
UHRF2 ubiquitinated TIP60 and further stabilized its
expression and elevated its activity via RING ﬁnger domain
in normal cells. Conversely, the expression and activity of
TIP60 were decreased in tumor cells. These results are of
utmost signiﬁcance, with two diametrically opposite respon-
ses in different cells. We conjectured that a series of
unknown signal transduction factors mediate this pathway,
which remain to be investigated.
PTMs associated with gene expression usually occur at
the amino acid level, including methylation, phosphorylation,
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(Holt et al., 2015; Kouzarides 2007; Li 2002). Histone
acetylation is one of the reversible PTMs catalyzed by HATs
and HDACs, which play a key role in the regulation of
speciﬁc gene expression, chromosome segregation and
leukemia (Basu et al., 2009; Wang et al., 2008). Histone
acetylation alters the chromosome structure and gene
activity, and triggers the initiation and progression of tumors
via regulation of cellular proliferation and apoptosis
(Pokholok et al., 2005). The proliferation and differentiation
levels are balanced under normal conditions through s series
of molecular regulatory mechanisms (Tan et al., 2011).
Normal cells transform into tumor cells when the balance of
histone acetylation and deacetylation is disrupted by physi-
cal, chemical and biological factors to trigger abnormal dif-
ferentiation and chaotic proliferation (Su et al., 2016).
Histone H3 is a core component of eukaryotic nucleosome
octamer (Karmodiya et al., 2012; Yamada et al., 2013). The
two lysine sites 9 and 14 are the focus of intensive study in
histone acetylation (Karmodiya et al., 2012). H3K9ac is
associated with meiotic recombination hotspots and DNA
damage response, and plays a key role in recombination
with other factors (Grezy et al., 2016). H3K14ac interacts
HEK293
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Figure 4. UHRF2 uniquitinates and stabilizes TIP60 in vivo. (A–C) HEK293, LO2 and HepG2 cells were transfected with control,
Flag-UHRF2 or ΔRING plasmids, respectively. The cellular lysates were analyzed by Western blot. Graph represents collated results
from three independent half-life experiments performed in HEK293, LO2 and HepG2 cells. TIP60 levels were normalized to 1 at time
zero. (D–E) Various plasmids as shown were transfected into HEK293 and HepG2 cells. The cellular lysates were immunopre-
cipitated with anti-HA antibodies and immunoblotted with anti-TIP60 antibodies.
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Figure 5. UHRF2 regulates H3K9ac and H3K14ac via TIP60. (A–C) HEK293, LO2 and HepG2 cells were transfected with Flag-
UHRF2 plasmid, either alone or in combination with siRNA against TIP60. After 48 h, the cellular lysates were analyzed by Western
blot. (D–F) HEK293, LO2 and HepG2 cells were transfected with Flag-UHRF2 plasmid, either alone or in combination with His-TIP60
plasmid. Total cellular lysates were analyzed by Western blot. Data represent means ± SD and were examined with two-sided t-test;
*P < 0.05; n.s (non-signiﬁcant) indicated as P > 0.05. (G–I) HEK293, LO2 and Hepg2 cells were transfected with various plasmids as
shown and treated with MG149 (100 μm) after transfection. Cellular lysates were analyzed by Western blot.
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with transcription factors in tumor initiation and progression
(Pichler et al., 2011). In this study, we found that UHRF2
regulated H3K9ac and H3K14ac expression via YDG and
RING ﬁnger domain, and contrasting results were found in
normal and cancer cells. In addition, we found that TIP60
elevated the expression of H3K9ac and H3K14ac. Based on
these results, we investigated the UHRF2-mediated regula-
tion of H3K9ac and H3K14ac via interaction with TIP60, and
ubiquitination of TIP60 as a new substrate of E3 ligase
UHRF2. Interestingly, the differential regulatory mechanism
of UHRF2 against TIP60 in normal and cancer cells attracted
our attention and investigation.
In summary, we suggest that UHRF2 regulated H3K9ac
and H3K14ac expression via the TIP60 downstream signal.
It is widely believed that cellular protein-protein interactions
are universal. However, in this study, contrasting results
were repeatedly found in normal and cancer cells. We used
immunohistochemical analysis of HCC tissues and similar
results were obtained. The differences in normal and cancer
cells were the focus of this study, although we found that an
intermediate signaling molecule “TIP60” participated in this
mechanism. However, several unknown factors remain to be
further investigated. We hypothesized that this mechanism
includes speciﬁc signal transduction pathways, which trigger
carcinogenesis in normal cells, and promote or co-promote
malignant transformation of cells.
MATERIALS AND METHODS
Cell lines and cell culture
Human normal liver cells (LO2) were cultured in RPMI-1640 medium
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embryonic kidney 293 cells (HEK293) and human hepatocellular
liver carcinoma cells (HepG2) were routinely cultured in DMEM/
HIGH glucose medium (Hyclone, USA) with 10% fetal bovine serum
(Gibco). In this study, HEK293 and LO2 cells were regarded as
normal cells. HepG2 cells were regarded as cancer cells.
Plasmids and siRNAs
Full-length and mutant UHRF2 genes (Flag-UHRF2, ΔUBL, ΔYDG,
ΔPHD, ΔRING) were obtained by cloning the PCR fragment corre-
sponding to UHRF2 into the pCMV-3×Flag vector. The pcDNA3.0-
HA-Ub was a kind gift obtained from Lu Bai (Fudan University). The
pcDNA3.1-His-TIP60, short hairpin RNA (shRNA) against UHRF2
and small interfering RNA (siRNA) against TIP60 were purchased
from Invitrogen (USA) and GenePhama (China), respectively.
Transfection was performed using Lipofectamine 2000 reagent (In-
vitrogen) according to the manufacturer’s instructions.
Western blot
Total protein was isolated with RIPA lysis buffer (Beyotime
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Figure 6. TIP60 and UHRF2 were negatively correlated in HCC tissues. (A) Immunohistochemistry with indicated antibodies in
HCC tissues. UHRF2 showed a high expression in group “a” and low expression in group “b”. (B) Immunohistochemical analysis
using the indicated antibodies in adjacent non-tumor tissues. UHRF2 showed a high expression in group “a” and low expression in
group “b”. (C) Model of UHRF2-TIP60-H3K9ac and H3K14ac signaling axis.
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ﬂuoride (PMSF) (Roche, Germany) and a protease inhibitor cocktail
(Roche) after 48 h transfection. Protein concentrations were mea-
sured using a BCA protein assay Kit (Beyotime Biotechnology) and
boiled in loading buffer containing 1% SDS before infection. Proteins
were separated by SDS-PAGE followed by Western blot with the
indicated antibodies. The primary and secondary antibodies are
listed in Table S1.
Tissue samples and immunohistochemistry
Forty-ﬁve cases of HCC tissue samples were collected from patients
who underwent surgical resection at the department of the First
Afﬁliated Hospital of Chongqing Medical University. The study was
approved by the Ethics Committee of Chongqing Medical University
(reference number: 2015018). All subjects signed informed consent.
Patients’ information will not be disclosed completely.
Immunohistochemistry was performed as described elsewhere
(Das et al., 2016).
Co-immunoprecipitation
Cells were lysed with NP40 lysis buffer (Beyotime Biotechnology)
supplemented with PMSF and a protease inhibitor cocktail at 48 h
after transfection. The whole cell extracts were immunoprecipitated
overnight at 4°C with the indicated antibody. After extensive washing
with lysis buffer, the immune complexes were boiled in a loading
buffer containing 1% SDS to deplete the interference of poly-ubiq-
uitin chain on the other molecules in the same complex, and ana-
lyzed by Western blot.
Ubiquitination assay
To detect ubiquitinated TIP60 proteins, cells in a 10 mL cell bottle
were transiently transfected with 4 μg HA-ubiquitin-expressing
plasmids together with the indicated plasmid. Twelve hours before
collection, cells were treated with 20 μmol/L of MG132 (Sigma-
Aldrich, USA). Cells were lysed using NP40 lysis buffer supple-
mented with PMSF and protease inhibitor cocktail. The following
procedures were identical to the immunoprecipitation assay except
for the use of monoclonal HA antibody.
Half-life experiments
Cells were treated with 100 μg/mL of cycloheximide (CHX) (ABmole
Bioscience, USA) for the indicated times, to inhibit protein synthesis.
The cellular lysates were analyzed by Western blot.
Immunoﬂuorescence
Cells seeded on the coverslips were ﬁxed in 4% paraformaldehyde,
and incubated with primary antibodies and secondary antibodies
before staining with DAPI, mounted and observed, as described
elsewhere (Liang et al., 2016; Takase et al., 2016).
Statistics analysis
All statistical data are described in the ﬁgure legends. Two-sided
unpaired Student’s t-test was used for experimental comparisons,
after quantiﬁcation with Image J software. Signiﬁcance was
represented as *P < 0.05, and non-signiﬁcance was indicated as n.s
P > 0.05.
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